SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-07-08 16:43
Tx date 2021-07-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-32,814
-3,646 vol
$9.00 each
0
Filed 2021-07-08 16:42
Tx date 2021-07-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$1,385
+3,646 vol
$0.38 each
3,646
Filed 2021-07-08 16:40
Tx date 2021-07-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-1,385.48
-3,646 vol
$0.38 each
81,427
Filed 2021-07-02 13:18
Tx date 2021-07-01
$TRIL
Trillium Therapeutics Inc.
Mackey, Catherine Jane
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$649,900
+67,000 vol
$9.70 each
67,000
Filed 2021-06-30 13:15
Tx date 2021-06-30
$TRIL
Trillium Therapeutics Inc.
Mackey, Catherine Jane
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-08 17:49
Tx date 2021-06-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-30,152.42
-3,646 vol
$8.27 each
0
Filed 2021-06-08 17:48
Tx date 2021-06-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$1,385
+3,646 vol
$0.38 each
3,646
Filed 2021-06-08 17:45
Tx date 2021-06-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-1,385.48
-3,646 vol
$0.38 each
85,073
Filed 2021-05-18 10:52
Tx date 2021-05-13
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
90 - Change in the nature of ownership

+133,555 vol
408,555
Filed 2021-05-18 10:50
Tx date 2021-05-13
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-133,555 vol
1,550,945
Filed 2021-05-13 18:07
Tx date 2021-05-12
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-219,880.4958
-23,802 vol
$9.24 each
0
Filed 2021-05-13 18:06
Tx date 2021-05-12
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$9,044
+23,802 vol
$0.38 each
23,802
Filed 2021-05-13 18:04
Tx date 2021-05-12
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-9,044.76
-23,802 vol
$0.38 each
1,684,500
Filed 2021-05-13 18:03
Tx date 2021-05-11
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-176,654.2366
-19,198 vol
$9.20 each
0
Filed 2021-05-13 18:02
Tx date 2021-05-11
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$7,295
+19,198 vol
$0.38 each
19,198
Filed 2021-05-13 18:00
Tx date 2021-05-11
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-7,295.24
-19,198 vol
$0.38 each
1,708,302
Filed 2021-05-13 17:59
Tx date 2021-05-11
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-805,148.75
-87,500 vol
$9.20 each
0
Filed 2021-05-13 17:57
Tx date 2021-05-11
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$47,250
+87,500 vol
$0.54 each
87,500
Filed 2021-05-13 17:56
Tx date 2019-09-25
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-13 17:53
Tx date 2021-05-11
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-47,250
-87,500 vol
$0.54 each
1,727,500
Filed 2021-05-10 17:20
Tx date 2021-05-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-33,907.80
-3,646 vol
$9.30 each
0
Filed 2021-05-10 17:19
Tx date 2021-05-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$1,385
+3,646 vol
$0.38 each
3,646
Filed 2021-05-10 17:17
Tx date 2021-05-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-1,385.48
-3,646 vol
$0.38 each
88,719
Filed 2021-05-04 17:37
Tx date 2021-05-03
$TRIL
Trillium Therapeutics Inc.
Looker, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,806,900
+190,000 vol
$9.51 each
190,000
Filed 2021-05-04 17:32
Tx date 2021-04-26
$TRIL
Trillium Therapeutics Inc.
Looker, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-04 09:05
Tx date 2021-05-03
$TRIL
Trillium Therapeutics Inc.
Myers, Scott Dunseth
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$637,170
+67,000 vol
$9.51 each
67,000
Filed 2021-04-28 16:52
Tx date 2021-04-28
$TRIL
Trillium Therapeutics Inc.
Myers, Scott Dunseth
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-04-09 17:11
Tx date 2021-04-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-39,449.72
-3,646 vol
$10.82 each
0
Filed 2021-04-09 17:10
Tx date 2021-04-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$1,385
+3,646 vol
$0.38 each
3,646
Filed 2021-04-09 17:09
Tx date 2021-04-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-1,385.48
-3,646 vol
$0.38 each
92,365
Filed 2021-04-09 15:16
Tx date 2021-04-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-28,878.36
-2,604 vol
$11.09 each
0
Filed 2021-04-09 15:15
Tx date 2021-04-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$11,014
+2,604 vol
$4.23 each
2,604
Filed 2021-04-09 15:13
Tx date 2021-04-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-11,014.92
-2,604 vol
$4.23 each
68,929
Filed 2021-04-09 15:11
Tx date 2021-04-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-30,031.72
-2,708 vol
$11.09 each
0
Filed 2021-04-09 15:10
Tx date 2021-04-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$1,029
+2,708 vol
$0.38 each
2,708
Filed 2021-04-09 15:08
Tx date 2021-04-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-1,029.04
-2,708 vol
$0.38 each
71,533
Filed 2021-03-15 14:36
Tx date 2021-03-12
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-34,916.49
-2,917 vol
$11.97 each
0
Filed 2021-03-15 14:34
Tx date 2021-03-12
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$12,338
+2,917 vol
$4.23 each
2,917
Filed 2021-03-15 14:31
Tx date 2021-03-12
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-12,338.91
-2,917 vol
$4.23 each
96,011
Filed 2021-03-12 15:43
Tx date 2021-03-10
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-28,852.32
-2,604 vol
$11.08 each
0
Filed 2021-03-12 15:42
Tx date 2021-03-10
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$11,014
+2,604 vol
$4.23 each
2,604
Filed 2021-03-12 15:37
Tx date 2021-03-10
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-11,014.92
-2,604 vol
$4.23 each
74,241
Filed 2021-03-12 15:34
Tx date 2021-03-10
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-30,004.64
-2,708 vol
$11.08 each
0
Filed 2021-03-12 15:33
Tx date 2021-03-10
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$1,029
+2,708 vol
$0.38 each
2,708
Filed 2021-03-12 15:29
Tx date 2021-03-10
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-1,029.04
-2,708 vol
$0.38 each
76,845
Filed 2021-03-10 13:47
Tx date 2021-03-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-36,861.06
-3,646 vol
$10.11 each
0
Filed 2021-03-10 13:47
Tx date 2021-03-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$1,385
+3,646 vol
$0.38 each
3,646
Filed 2021-03-10 13:44
Tx date 2021-03-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-1,385.48
-3,646 vol
$0.38 each
98,928
Filed 2021-02-10 20:38
Tx date 2021-02-09
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-8,248.416
-584 vol
$14.12 each
0
Filed 2021-02-10 20:37
Tx date 2021-02-09
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$7,136
+584 vol
$12.22 each
584
Filed 2021-02-10 20:36
Tx date 2021-02-09
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-7,136.48
-584 vol
$12.22 each
102,574
Filed 2021-02-10 20:35
Tx date 2021-02-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-36,900.05
-2,917 vol
$12.65 each
0
Filed 2021-02-10 20:34
Tx date 2021-02-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$12,338
+2,917 vol
$4.23 each
2,917
Filed 2021-02-10 20:33
Tx date 2021-02-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-12,338.91
-2,917 vol
$4.23 each
103,158
Filed 2021-02-10 20:31
Tx date 2021-02-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-46,121.90
-3,646 vol
$12.65 each
0
Filed 2021-02-10 20:30
Tx date 2021-02-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$1,385
+3,646 vol
$0.38 each
3,646
Filed 2021-02-10 20:29
Tx date 2021-02-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-1,385.48
-3,646 vol
$0.38 each
106,075
Filed 2021-02-10 20:27
Tx date 2021-02-09
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-7,200.392
-508 vol
$14.17 each
0
Filed 2021-02-10 20:25
Tx date 2021-02-09
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$6,207
+508 vol
$12.22 each
508
Filed 2021-02-10 20:24
Tx date 2021-02-09
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-6,207.76
-508 vol
$12.22 each
79,553
Filed 2021-02-10 20:14
Tx date 2021-02-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-32,940.60
-2,604 vol
$12.65 each
0
Filed 2021-02-10 20:13
Tx date 2021-02-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$11,014
+2,604 vol
$4.23 each
2,604
Filed 2021-02-10 20:12
Tx date 2021-02-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-11,014.92
-2,604 vol
$4.23 each
80,061
Filed 2021-02-10 20:07
Tx date 2021-02-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-34,256.20
-2,708 vol
$12.65 each
0
Filed 2021-02-10 20:05
Tx date 2021-02-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$1,029
+2,708 vol
$0.38 each
2,708
Filed 2021-02-10 20:00
Tx date 2021-02-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-1,029.04
-2,708 vol
$0.38 each
82,665
Filed 2021-01-15 17:31
Tx date 2021-01-14
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-294,278.9328
-19,581 vol
$15.03 each
0
Filed 2021-01-15 17:30
Tx date 2021-01-14
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
51 - Exercise of options
$10,573
+19,581 vol
$0.54 each
19,581
Filed 2021-01-15 17:29
Tx date 2021-01-14
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
51 - Exercise of options
$-10,573.74
-19,581 vol
$0.54 each
275,000
Filed 2021-01-15 17:28
Tx date 2021-01-13
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-81,507.7209
-5,419 vol
$15.04 each
0
Filed 2021-01-15 17:27
Tx date 2021-01-13
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
51 - Exercise of options
$2,926
+5,419 vol
$0.54 each
5,419
Filed 2021-01-15 17:21
Tx date 2021-01-13
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
51 - Exercise of options
$-2,926.26
-5,419 vol
$0.54 each
294,581
Filed 2021-01-12 19:42
Tx date 2021-01-11
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-8,878.6688
-584 vol
$15.20 each
0
Filed 2021-01-12 19:41
Tx date 2021-01-11
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$7,136
+584 vol
$12.22 each
584
Filed 2021-01-12 19:40
Tx date 2021-01-11
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-7,136.48
-584 vol
$12.22 each
109,721
Filed 2021-01-12 19:39
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-45,230.4186
-2,917 vol
$15.51 each
0
Filed 2021-01-12 19:38
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$12,338
+2,917 vol
$4.23 each
2,917
Filed 2021-01-12 19:37
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-12,338.91
-2,917 vol
$4.23 each
110,305
Filed 2021-01-12 19:36
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-88,575.20
-5,600 vol
$15.82 each
0
Filed 2021-01-12 19:32
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$78,288
+5,600 vol
$13.98 each
5,600
Filed 2021-01-12 19:31
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-78,288
-5,600 vol
$13.98 each
113,222
Filed 2021-01-12 19:29
Tx date 2021-01-11
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-7,725.3084
-508 vol
$15.21 each
0
Filed 2021-01-12 19:28
Tx date 2021-01-11
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$6,207
+508 vol
$12.22 each
508
Filed 2021-01-12 19:26
Tx date 2021-01-11
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-6,207.76
-508 vol
$12.22 each
85,373
Filed 2021-01-12 19:25
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-40,364.604
-2,604 vol
$15.50 each
0
Filed 2021-01-12 19:22
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$11,014
+2,604 vol
$4.23 each
2,604
Filed 2021-01-12 19:21
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-11,014.92
-2,604 vol
$4.23 each
85,881
Filed 2021-01-12 16:58
Tx date 2021-01-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-53,782.146
-3,646 vol
$14.75 each
0
Filed 2021-01-12 16:56
Tx date 2021-01-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$1,385
+3,646 vol
$0.38 each
3,646
Filed 2021-01-12 16:55
Tx date 2021-01-07
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-1,385.48
-3,646 vol
$0.38 each
118,822
Filed 2021-01-12 16:41
Tx date 2021-01-07
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-39,842.804
-2,708 vol
$14.71 each
0
Filed 2021-01-12 16:38
Tx date 2021-01-07
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$1,029
+2,708 vol
$0.38 each
2,708
Filed 2021-01-12 16:35
Tx date 2021-01-07
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-1,029.04
-2,708 vol
$0.38 each
88,485
Filed 2021-01-12 12:21
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-134,270.9865
-8,505 vol
$15.79 each
0
Filed 2021-01-12 12:19
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$78,246
+8,505 vol
$9.20 each
8,505
Filed 2021-01-12 12:12
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-78,246
-8,505 vol
$9.20 each
173,492
Filed 2021-01-04 13:45
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-307,104.684
-21,621 vol
$14.20 each
0
Filed 2021-01-04 13:43
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$264,208
+21,621 vol
$12.22 each
21,621
Filed 2021-01-04 13:42
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-264,208.62
-21,621 vol
$12.22 each
122,468
Filed 2021-01-04 13:39
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-562,638.384
-38,808 vol
$14.50 each
0
Filed 2021-01-04 13:38
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$542,535
+38,808 vol
$13.98 each
38,808
Filed 2021-01-04 13:37
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-272,562.40
-18,800 vol
$14.50 each
0
Filed 2021-01-04 13:37
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$229,736
+18,800 vol
$12.22 each
18,800
Filed 2021-01-04 13:35
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-542,535.84
-38,808 vol
$13.98 each
91,193
Filed 2021-01-04 13:34
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-229,736
-18,800 vol
$12.22 each
130,001
Filed 2021-01-04 13:32
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-398,751.45
-26,970 vol
$14.79 each
0
Filed 2021-01-04 13:30
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$224,929
+26,970 vol
$8.34 each
26,970
Filed 2021-01-04 13:29
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-62,836.25
-4,250 vol
$14.79 each
0
Filed 2021-01-04 13:28
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$31,875
+4,250 vol
$7.50 each
4,250
Filed 2021-01-04 13:26
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-224,929.80
-26,970 vol
$8.34 each
181,997
Filed 2021-01-04 13:24
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-31,875
-4,250 vol
$7.50 each
208,967
Filed 2020-12-31 16:42
Tx date 2020-11-12
$TRIL
Trillium Therapeutics Inc.
Bruns, Ingmar
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+400,000 vol
400,000
Filed 2020-12-31 16:40
Tx date 2020-11-12
$TRIL
Trillium Therapeutics Inc.
Harrison, Rosemary
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+180,000 vol
180,000
Filed 2020-12-28 22:14
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Walker, Paul
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
40,000
Filed 2020-12-28 22:13
Tx date 2020-02-06
$TRIL
Trillium Therapeutics Inc.
Walker, Paul
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-28 17:06
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Reynolds, Thomas
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$3,948 vol
$12.03 each
$518,234
Filed 2020-12-28 17:05
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Reynolds, Thomas
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$3,948 vol
$12.03 each
Filed 2020-12-28 16:58
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Tayton-Martin, Helen Katrina
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$3,948 vol
$12.03 each
$498,294
Filed 2020-12-28 16:57
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Tayton-Martin, Helen Katrina
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$3,948 vol
$12.03 each
Filed 2020-12-28 16:43
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
46,667
Filed 2020-12-28 16:42
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
Filed 2020-12-28 16:37
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+140,000 vol
247,895
Filed 2020-12-28 16:34
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+180,000 vol
287,893
Filed 2020-12-28 16:32
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+600,000 vol
1,815,000
Filed 2020-12-28 16:31
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+600,000 vol
Filed 2020-12-28 16:30
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+250,000 vol
386,795
Filed 2020-12-28 16:28
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+600,000 vol
Filed 2020-12-28 16:25
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Tayton-Martin, Helen Katrina
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$3,948 vol
$12.03 each
Filed 2020-12-28 16:24
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Tayton-Martin, Helen Katrina
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
40,000
Filed 2020-12-28 16:23
Tx date 2017-09-13
$TRIL
Trillium Therapeutics Inc.
Tayton-Martin, Helen Katrina
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-28 16:22
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Reynolds, Thomas
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$3,948 vol
$12.03 each
Filed 2020-12-28 16:22
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Reynolds, Thomas
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$3,948 vol
$12.03 each
$518,234
Filed 2020-12-28 16:20
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Reynolds, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
116,667
Filed 2020-12-28 16:16
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$1,974 vol
$12.03 each
$463,993
Filed 2020-12-28 16:14
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other

+1,974 vol
Filed 2020-12-28 16:11
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Beshar, Luke
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$3,948 vol
$12.03 each
$539,025
Filed 2020-12-28 16:05
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Beshar, Luke
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
46,667
Filed 2020-12-28 16:02
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other

+1,974 vol
Filed 2020-12-28 15:50
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
Filed 2020-12-28 15:50
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
46,667
Filed 2020-12-18 21:41
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-884,115
-75,000 vol
$11.79 each
0
Filed 2020-12-18 21:40
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
51 - Exercise of options
$28,500
+75,000 vol
$0.38 each
75,000
Filed 2020-12-18 21:39
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-414,143.0424
-35,132 vol
$11.79 each
0
Filed 2020-12-18 21:39
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
51 - Exercise of options
$18,971
+35,132 vol
$0.54 each
35,132
Filed 2020-12-18 21:31
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
51 - Exercise of options
$-28,500
-75,000 vol
$0.38 each
300,000
Filed 2020-12-18 21:30
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
51 - Exercise of options
$-18,971.28
-35,132 vol
$0.54 each
375,000
Filed 2020-12-18 21:29
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-1,857,429.9294
-161,094 vol
$11.53 each
0
Filed 2020-12-18 21:28
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
51 - Exercise of options
$86,990
+161,094 vol
$0.54 each
161,094
Filed 2020-12-18 21:27
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
51 - Exercise of options
$-86,990.76
-161,094 vol
$0.54 each
410,132
Filed 2020-12-18 21:26
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-335,289.035
-28,774 vol
$11.65 each
0
Filed 2020-12-18 21:25
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
51 - Exercise of options
$15,537
+28,774 vol
$0.54 each
28,774
Filed 2020-12-18 21:23
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
51 - Exercise of options
$-15,537.96
-28,774 vol
$0.54 each
571,226
Filed 2020-12-18 21:22
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-1,325,262.9708
-114,007 vol
$11.62 each
0
Filed 2020-12-18 21:21
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
51 - Exercise of options
$61,563
+114,007 vol
$0.54 each
114,007
Filed 2020-12-18 21:20
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
51 - Exercise of options
$-61,563.78
-114,007 vol
$0.54 each
600,000
Filed 2020-12-18 21:18
Tx date 2020-12-18
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-264,489.7332
-21,693 vol
$12.19 each
0
Filed 2020-12-18 21:17
Tx date 2020-12-18
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$8,243
+21,693 vol
$0.38 each
21,693
Filed 2020-12-18 21:16
Tx date 2020-12-18
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-8,243.34
-21,693 vol
$0.38 each
144,089
Filed 2020-12-18 21:15
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-304,694.6398
-25,702 vol
$11.85 each
0
Filed 2020-12-18 21:14
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$9,766
+25,702 vol
$0.38 each
25,702
Filed 2020-12-18 21:13
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-9,766.76
-25,702 vol
$0.38 each
165,782
Filed 2020-12-18 21:12
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-802,363.3418
-67,682 vol
$11.85 each
0
Filed 2020-12-18 21:11
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$52,115
+67,682 vol
$0.77 each
67,682
Filed 2020-12-18 21:07
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-52,115.14
-67,682 vol
$0.77 each
191,484
Filed 2020-12-18 21:06
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-796,296.501
-69,069 vol
$11.53 each
0
Filed 2020-12-18 21:05
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$53,183
+69,069 vol
$0.77 each
69,069
Filed 2020-12-18 21:04
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-53,183.13
-69,069 vol
$0.77 each
259,166
Filed 2020-12-18 21:03
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-154,085.87
-13,249 vol
$11.63 each
0
Filed 2020-12-18 21:02
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$10,201
+13,249 vol
$0.77 each
13,249
Filed 2020-12-18 21:01
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-10,201.73
-13,249 vol
$0.77 each
328,235
Filed 2020-12-18 20:58
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-672,609.42
-57,834 vol
$11.63 each
0
Filed 2020-12-18 20:57
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$244,637
+57,834 vol
$4.23 each
57,834
Filed 2020-12-18 20:55
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-244,637.82
-57,834 vol
$4.23 each
341,484
Filed 2020-12-18 20:51
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-50,361.65
-4,250 vol
$11.85 each
0
Filed 2020-12-18 20:49
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$31,875
+4,250 vol
$7.50 each
4,250
Filed 2020-12-18 20:48
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-239,674.0548
-20,226 vol
$11.85 each
0
Filed 2020-12-18 20:47
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$168,684
+20,226 vol
$8.34 each
20,226
Filed 2020-12-18 20:46
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-164,131.5798
-13,851 vol
$11.85 each
0
Filed 2020-12-18 20:43
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$127,429
+13,851 vol
$9.20 each
13,851
Filed 2020-12-18 20:42
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-309,149.4322
-26,089 vol
$11.85 each
0
Filed 2020-12-18 20:40
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$270,021
+26,089 vol
$10.35 each
26,089
Filed 2020-12-18 20:39
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-199,977.2248
-16,876 vol
$11.85 each
0
Filed 2020-12-18 20:38
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$71,385
+16,876 vol
$4.23 each
16,876
Filed 2020-12-18 20:36
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-556,020.612
-48,228 vol
$11.53 each
0
Filed 2020-12-18 20:36
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$204,004
+48,228 vol
$4.23 each
48,228
Filed 2020-12-18 20:33
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-163,377.459
-14,171 vol
$11.53 each
0
Filed 2020-12-18 20:31
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$5,384
+14,171 vol
$0.38 each
14,171
Filed 2020-12-18 20:29
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-244,660.31
-21,037 vol
$11.63 each
0
Filed 2020-12-18 20:28
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$7,994
+21,037 vol
$0.38 each
21,037
Filed 2020-12-18 20:27
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-501,159.96
-43,092 vol
$11.63 each
0
Filed 2020-12-18 20:26
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$33,180
+43,092 vol
$0.77 each
43,092
Filed 2020-12-18 20:24
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-31,875
-4,250 vol
$7.50 each
148,801
Filed 2020-12-18 20:16
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-168,684.84
-20,226 vol
$8.34 each
153,051
Filed 2020-12-18 20:16
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-127,429.20
-13,851 vol
$9.20 each
173,277
Filed 2020-12-18 20:14
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-270,021.15
-26,089 vol
$10.35 each
187,128
Filed 2020-12-18 20:13
Tx date 2020-12-17
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-71,385.48
-16,876 vol
$4.23 each
213,217
Filed 2020-12-18 20:12
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-204,004.44
-48,228 vol
$4.23 each
230,093
Filed 2020-12-18 20:11
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-5,384.98
-14,171 vol
$0.38 each
278,321
Filed 2020-12-18 20:10
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-7,994.06
-21,037 vol
$0.38 each
292,492
Filed 2020-12-18 20:09
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
52 - Expiration of options
$-33,180.84
-43,092 vol
$0.77 each
313,529
Filed 2020-12-18 20:00
Tx date 2020-12-18
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-827,940.5888
-65,104 vol
$12.72 each
0
Filed 2020-12-18 19:59
Tx date 2020-12-18
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$275,389
+65,104 vol
$4.23 each
65,104
Filed 2020-12-18 19:58
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-160,186.382
-14,162 vol
$11.31 each
0
Filed 2020-12-18 19:57
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$5,381
+14,162 vol
$0.38 each
14,162
Filed 2020-12-18 19:56
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-244,764.98
-21,046 vol
$11.63 each
0
Filed 2020-12-18 19:55
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$7,997
+21,046 vol
$0.38 each
21,046
Filed 2020-12-18 19:53
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-501,159.96
-43,092 vol
$11.63 each
0
Filed 2020-12-18 19:52
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$33,180
+43,092 vol
$0.77 each
43,092
Filed 2020-12-18 19:51
Tx date 2020-12-18
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-275,389.92
-65,104 vol
$4.23 each
213,217
Filed 2020-12-18 19:50
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-5,381.56
-14,162 vol
$0.38 each
278,321
Filed 2020-12-18 19:49
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-7,997.48
-21,046 vol
$0.38 each
292,483
Filed 2020-12-18 19:47
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-33,180.84
-43,092 vol
$0.77 each
313,529
Filed 2020-12-18 19:41
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-2,195,461.372
-185,993 vol
$11.80 each
0
Filed 2020-12-18 19:40
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
51 - Exercise of options
$100,436
+185,993 vol
$0.54 each
185,993
Filed 2020-12-18 19:38
Tx date 2019-09-25
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 19:37
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
51 - Exercise of options
$-100,436.22
-185,993 vol
$0.54 each
714,007
Filed 2020-12-18 19:36
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-177,135.0736
-15,082 vol
$11.74 each
0
Filed 2020-12-18 19:34
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$63,796
+15,082 vol
$4.23 each
15,082
Filed 2020-12-18 19:33
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-63,796.86
-15,082 vol
$4.23 each
399,318
Filed 2020-12-18 19:32
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-99,842.5448
-8,501 vol
$11.74 each
0
Filed 2020-12-18 19:31
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$63,757
+8,501 vol
$7.50 each
8,501
Filed 2020-12-18 19:30
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-63,757.50
-8,501 vol
$7.50 each
414,400
Filed 2020-12-18 19:29
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-395,952.4424
-33,713 vol
$11.74 each
0
Filed 2020-12-18 19:28
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$281,166
+33,713 vol
$8.34 each
33,713
Filed 2020-12-18 19:27
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-281,166.42
-33,713 vol
$8.34 each
422,901
Filed 2020-12-18 19:26
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-245,595.5128
-20,911 vol
$11.74 each
0
Filed 2020-12-18 19:25
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$192,381
+20,911 vol
$9.20 each
20,911
Filed 2020-12-18 19:23
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-192,381.20
-20,911 vol
$9.20 each
456,614
Filed 2020-12-18 19:21
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-494,056.7568
-42,066 vol
$11.74 each
0
Filed 2020-12-18 19:20
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$435,383
+42,066 vol
$10.35 each
42,066
Filed 2020-12-18 19:19
Tx date 2013-04-09
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 19:18
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-435,383.10
-42,066 vol
$10.35 each
477,525
Filed 2020-12-18 19:15
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-1,255,613.0784
-106,908 vol
$11.74 each
0
Filed 2020-12-18 19:13
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$82,319
+106,908 vol
$0.77 each
106,908
Filed 2020-12-18 19:11
Tx date 2013-04-09
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 19:10
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-82,319.16
-106,908 vol
$0.77 each
356,621
Filed 2020-12-18 19:06
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-1,255,613.0784
-106,908 vol
$11.74 each
0
Filed 2020-12-18 19:05
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$82,319
+106,908 vol
$0.77 each
106,908
Filed 2020-12-18 19:03
Tx date 2011-08-25
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 18:42
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Shou, Yaping
5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
90 - Change in the nature of ownership

+275,833 vol
275,833
Filed 2020-12-18 18:40
Tx date 2018-06-11
$TRIL
Trillium Therapeutics Inc.
Shou, Yaping
5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 18:21
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-82,319.16
-106,908 vol
$0.77 each
356,621
Filed 2020-12-18 18:12
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Shou, Yaping
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-275,833 vol
379,167
Filed 2020-12-18 18:09
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
90 - Change in the nature of ownership

+900,000 vol
900,000
Filed 2020-12-18 18:07
Tx date 2019-09-25
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 18:06
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-900,000 vol
1,215,000
Filed 2020-12-18 18:04
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
90 - Change in the nature of ownership

+519,591 vol
519,591
Filed 2020-12-18 18:01
Tx date 2013-04-09
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 18:00
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-519,591 vol
136,795
Filed 2020-12-18 17:58
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
90 - Change in the nature of ownership

+463,529 vol
463,529
Filed 2020-12-18 17:57
Tx date 2013-04-09
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:56
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-463,529 vol
107,895
Filed 2020-12-18 17:54
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-900,000 vol
Filed 2020-12-18 17:54
Tx date 2019-09-25
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:53
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-519,591 vol
Filed 2020-12-18 17:53
Tx date 2013-04-09
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:52
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
Options
97 - Other

-463,529 vol
Filed 2020-12-18 17:52
Tx date 2013-04-09
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:44
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
90 - Change in the nature of ownership

+463,529 vol
463,529
Filed 2020-12-18 17:42
Tx date 2011-08-25
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:40
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-463,529 vol
107,893
Filed 2020-12-18 17:34
Tx date 2011-08-25
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:33
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-463,529 vol
Filed 2020-12-18 17:27
Tx date 2019-09-25
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Merrill Lynch, Pierce, Fenner & Smith Incorporated (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:25
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-900,000 vol
Filed 2020-12-18 17:22
Tx date 2013-04-09
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:21
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-519,591 vol
Filed 2020-12-18 17:19
Tx date 2013-04-09
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:18
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
Options
97 - Other

-463,529 vol
Filed 2020-12-18 16:48
Tx date 2011-08-25
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
463,529
Filed 2020-12-18 16:48
Tx date 2011-08-25
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 16:44
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-463,529 vol
Filed 2020-12-18 16:44
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-463,529 vol
107,893
Filed 2020-11-17 10:44
Tx date 2020-11-15
$TRIL
Trillium Therapeutics Inc.
Pucci, Paolo
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$1,038,500
+67,000 vol
$15.50 each
67,000
Filed 2020-11-16 10:25
Tx date 2020-11-12
$TRIL
Trillium Therapeutics Inc.
Pucci, Paolo
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-11-09 10:32
Tx date 2020-11-05
$TRIL
Trillium Therapeutics Inc.
Harrison, Rosemary
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
75
Filed 2020-11-09 08:39
Tx date 2020-11-05
$TRIL
Trillium Therapeutics Inc.
Harrison, Rosemary
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-11-05 11:15
Tx date 2020-11-01
$TRIL
Trillium Therapeutics Inc.
Reynolds, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$249,000
+20,000 vol
$12.45 each
76,667
Filed 2020-11-05 11:13
Tx date 2020-11-01
$TRIL
Trillium Therapeutics Inc.
Reynolds, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$622,500
+50,000 vol
$12.45 each
56,667
Filed 2020-11-04 12:26
Tx date 2020-11-02
$TRIL
Trillium Therapeutics Inc.
Bruns, Ingmar
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-09-18 15:17
Tx date 2020-09-17
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Michael, Kamarck
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$989,590
+67,000 vol
$14.77 each
67,000
Filed 2020-09-18 15:10
Tx date 2020-09-17
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Michael, Kamarck
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-08 11:50
Tx date 2020-05-06
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
STILLER, CALVIN R.
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$13,737 vol
$4.87 each
$509,257
Filed 2020-05-08 11:47
Tx date 2020-05-06
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$13,737 vol
$4.87 each
$515,154
Filed 2020-01-02 16:52
Tx date 2019-12-31
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Tayton-Martin, Helen Katrina
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$14,792 vol
$1.16 each
$494,346
Filed 2020-01-02 16:50
Tx date 2019-12-31
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Reynolds, Thomas
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$16,205 vol
$1.16 each
$514,286
Filed 2020-01-02 16:48
Tx date 2019-12-31
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$13,965 vol
$1.16 each
$501,417
Filed 2020-01-02 16:46
Tx date 2019-12-31
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
STILLER, CALVIN R.
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$12,570 vol
$1.16 each
$495,520
Filed 2020-01-02 16:43
Tx date 2019-12-31
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Beshar, Luke
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$19,560 vol
$1.16 each
$535,077
Filed 2019-11-12 10:45
Tx date 2019-11-07
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$119,700
+315,000 vol
$0.38 each
2,115,000
Filed 2019-11-12 10:43
Tx date 2019-11-07
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Shou, Yaping
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$89,300
+235,000 vol
$0.38 each
655,000
Filed 2019-11-12 10:42
Tx date 2019-11-07
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$66,500
+175,000 vol
$0.38 each
656,386
Filed 2019-11-12 10:40
Tx date 2019-11-07
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$49,400
+130,000 vol
$0.38 each
571,424
Filed 2019-11-12 10:38
Tx date 2019-11-07
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$49,400
+130,000 vol
$0.38 each
571,422
Filed 2019-11-11 14:59
Tx date 2019-11-07
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
STILLER, CALVIN R.
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$348,333 vol
$0.36 each
$482,950
Filed 2019-11-11 14:57
Tx date 2019-11-07
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Tayton-Martin, Helen Katrina
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$348,333 vol
$0.36 each
$479,554
Filed 2019-11-11 14:55
Tx date 2019-11-07
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Reynolds, Thomas
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$348,333 vol
$0.36 each
$498,081
Filed 2019-11-11 14:54
Tx date 2019-11-07
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$348,333 vol
$0.36 each
$487,452
Filed 2019-11-11 14:52
Tx date 2019-11-07
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$113,568 vol
$0.36 each
$462,019
Filed 2019-11-11 14:46
Tx date 2019-11-07
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Beshar, Luke
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$348,333 vol
$0.36 each
$515,517
Filed 2019-10-02 15:33
Tx date 2019-09-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Tayton-Martin, Helen Katrina
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$39,154 vol
$0.4467 each
$131,221
Filed 2019-10-02 15:31
Tx date 2019-09-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Reynolds, Thomas
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$42,895 vol
$0.4467 each
$149,748
Filed 2019-10-02 15:30
Tx date 2019-09-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$36,967 vol
$0.4467 each
$139,119
Filed 2019-10-02 15:15
Tx date 2019-09-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Beshar, Luke
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$51,775 vol
$0.4467 each
$167,184
Filed 2019-10-02 15:10
Tx date 2019-09-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
STILLER, CALVIN R.
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$33,273 vol
$0.4467 each
$134,617
Filed 2019-09-27 15:42
Tx date 2019-09-25
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$972,000
+1,800,000 vol
$0.54 each
1,800,000
Filed 2019-09-27 09:49
Tx date 2019-09-25
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Skvarka, Jan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-07-03 16:44
Tx date 2019-06-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$43,250 vol
$0.4358 each
$348,451
Filed 2019-07-03 16:28
Tx date 2019-05-10
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$228,000 vol
$0.77 each
$305,201
Filed 2019-07-03 14:06
Tx date 2019-06-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Tayton-Martin, Helen Katrina
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$41,425 vol
$0.4358 each
$92,067
Filed 2019-07-03 14:04
Tx date 2019-06-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Reynolds, Thomas
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$42,531 vol
$0.4358 each
$106,853
Filed 2019-07-03 14:02
Tx date 2019-06-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$39,114 vol
$0.4358 each
$102,152
Filed 2019-07-03 14:00
Tx date 2019-06-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Beshar, Luke
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$49,286 vol
$0.4358 each
$115,409
Filed 2019-07-03 13:57
Tx date 2019-06-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
STILLER, CALVIN R.
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$32,161 vol
$0.4358 each
$101,344
Filed 2019-07-03 13:52
Tx date 2019-06-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$43,250 vol
$0.4358 each
Filed 2019-07-03 13:52
Tx date 2019-06-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$43,250 vol
$0.4358 each
$120,451
Filed 2019-05-27 12:54
Tx date 2019-05-10
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$115,500
+150,000 vol
$0.77 each
441,422
Filed 2019-05-27 12:51
Tx date 2019-05-10
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$115,500
+150,000 vol
$0.77 each
481,386
Filed 2019-05-27 12:42
Tx date 2019-05-10
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Shou, Yaping
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$115,500
+150,000 vol
$0.77 each
420,000
Filed 2019-05-27 12:21
Tx date 2019-05-10
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$115,500
+150,000 vol
$0.77 each
441,424
Filed 2019-04-05 10:14
Tx date 2019-03-31
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Tayton-Martin, Helen Katrina
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$19,614 vol
$0.92 each
$50,642
Filed 2019-04-05 10:12
Tx date 2019-03-31
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$18,531 vol
$0.92 each
$63,038
Filed 2019-04-05 10:09
Tx date 2019-03-31
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Reynolds, Thomas
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$19,815 vol
$0.92 each
$64,322
Filed 2019-04-05 10:06
Tx date 2019-03-31
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Beshar, Luke
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$21,616 vol
$0.92 each
$66,123
Filed 2019-04-05 10:02
Tx date 2019-03-31
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$23,177 vol
$0.92 each
$77,201
Filed 2019-04-05 09:58
Tx date 2019-03-31
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
STILLER, CALVIN R.
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$24,676 vol
$0.92 each
$69,183
Filed 2018-11-13
Tx date 2018-07-03
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Shou, Yaping
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,580,000
+200,000 vol
$7.90 each
200,000
Filed 2018-11-13
Tx date 2018-06-11
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Shou, Yaping
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-13
Tx date 2018-11-08
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Shou, Yaping
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$296,100
+70,000 vol
$4.23 each
270,000
Filed 2018-11-09
Tx date 2018-11-08
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$592,200
+140,000 vol
$4.23 each
331,386
Filed 2018-11-09
Tx date 2018-11-08
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$528,750
+125,000 vol
$4.23 each
291,424
Filed 2018-11-09
Tx date 2018-11-08
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$29,181 vol
$4.26 each
$44,507
Filed 2018-11-09
Tx date 2018-11-08
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Beshar, Luke
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$29,181 vol
$4.26 each
$44,507
Filed 2018-11-09
Tx date 2018-11-08
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,438,200
+340,000 vol
$4.23 each
1,022,332
Filed 2018-11-09
Tx date 2018-11-08
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$528,750
+125,000 vol
$4.23 each
291,422
Filed 2018-11-09
Tx date 2018-11-08
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Reynolds, Thomas
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$29,181 vol
$4.26 each
$44,507
Filed 2018-11-09
Tx date 2018-11-08
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
STILLER, CALVIN R.
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$29,181 vol
$4.26 each
$44,507
Filed 2018-11-09
Tx date 2018-11-08
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$29,181 vol
$4.26 each
$54,024
Filed 2018-11-09
Tx date 2018-11-08
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Tayton-Martin, Helen Katrina
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$29,181 vol
$4.26 each
$31,028
Filed 2018-05-29
Tx date 2018-05-24
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$4,791 vol
$7.83 each
$20,117
Filed 2018-05-17
Tx date 2018-05-10
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$9,517 vol
$7.88 each
$24,843
Filed 2017-11-14
Tx date 2017-09-13
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Tayton-Martin, Helen Katrina
4 - Director of Issuer
Direct Ownership
Deferred share units
00 - Opening Balance-Initial SEDI Report
Filed 2017-11-14
Tx date 2017-11-09
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
STILLER, CALVIN R.
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$7,390 vol
$12.18 each
$15,326
Filed 2017-11-14
Tx date 2017-11-09
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Reynolds, Thomas
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$7,390 vol
$12.18 each
$15,326
Filed 2017-11-14
Tx date 2017-11-09
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$7,390 vol
$12.18 each
$15,326
Filed 2017-11-14
Tx date 2017-11-09
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Kirkman, Robert Lawrence
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$7,390 vol
$12.18 each
$15,326
Filed 2017-11-14
Tx date 2017-11-09
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Beshar, Luke
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$7,390 vol
$12.18 each
$15,326
Filed 2017-11-14
Tx date 2017-11-09
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
FRIESEN, HENRY
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$7,390 vol
$12.18 each
$15,326
Filed 2017-11-14
Tx date 2017-11-09
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Tayton-Martin, Helen Katrina
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$1,847 vol
$12.18 each
$1,847
Filed 2017-11-13
Tx date 2017-11-09
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$298,045
+24,390 vol
$12.22 each
166,422
Filed 2017-11-13
Tx date 2017-11-09
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$342,758
+28,049 vol
$12.22 each
191,386
Filed 2017-11-13
Tx date 2017-11-09
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,222,000
+100,000 vol
$12.22 each
682,332
Filed 2017-11-13
Tx date 2017-11-09
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Sievers, Eric L
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$342,758
+28,049 vol
$12.22 each
191,386
Filed 2017-11-13
Tx date 2017-11-09
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$298,045
+24,390 vol
$12.22 each
166,424
Filed 2017-08-31
Tx date 2017-08-28
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Sievers, Eric L
5 - Senior Officer of Issuer
Holder: Eric and Nicole Sievers (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$49,173
+10,640 vol
$4.62 each
52,884
Filed 2017-08-21
Tx date 2017-08-17
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,760
+2,100 vol
$5.60 each
12,800
Filed 2017-08-21
Tx date 2017-08-21
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,210
+2,200 vol
$5.55 each
15,000
Filed 2017-08-18
Tx date 2017-08-16
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$22,464
+4,000 vol
$5.62 each
10,000
Filed 2017-08-18
Tx date 2017-08-17
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Stiernholm, Bjorn Johan Niclas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,955
+700 vol
$5.65 each
10,700